Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Linagliptin 1	5,732
Overall Study	STARTED	Any Other DPP-4	64,695
Overall Study	STARTED	Linagliptin 2	4,441
Overall Study	STARTED	Pioglitazone	14,363
Overall Study	STARTED	Linagliptin 3	3,436
Overall Study	STARTED	Second Generation Sulfonylurea	73,946
Overall Study	COMPLETED	Linagliptin 1	243
Overall Study	COMPLETED	Any Other DPP-4	3,041
Overall Study	COMPLETED	Linagliptin 2	205
Overall Study	COMPLETED	Pioglitazone	530
Overall Study	COMPLETED	Linagliptin 3	150
Overall Study	COMPLETED	Second Generation Sulfonylurea	3,050
Overall Study	NOT COMPLETED	Linagliptin 1	5,489
Overall Study	NOT COMPLETED	Any Other DPP-4	61,654
Overall Study	NOT COMPLETED	Linagliptin 2	4,236
Overall Study	NOT COMPLETED	Pioglitazone	13,833
Overall Study	NOT COMPLETED	Linagliptin 3	3,286
Overall Study	NOT COMPLETED	Second Generation Sulfonylurea	70,896

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02140645/flow